Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ACHILLION PHARMACEUTICALS INC | d323090d10k.htm |
| EX-10.28 - EX-10.28 - ACHILLION PHARMACEUTICALS INC | d323090dex1028.htm |
| EX-10.27 - EX-10.27 - ACHILLION PHARMACEUTICALS INC | d323090dex1027.htm |
| EX-32.2 - EX-32.2 - ACHILLION PHARMACEUTICALS INC | d323090dex322.htm |
| EX-31.2 - EX-31.2 - ACHILLION PHARMACEUTICALS INC | d323090dex312.htm |
| EX-31.1 - EX-31.1 - ACHILLION PHARMACEUTICALS INC | d323090dex311.htm |
| EX-32.1 - EX-32.1 - ACHILLION PHARMACEUTICALS INC | d323090dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-206276, 333-183152, 333-168902, 333-158241, 333-149729, 333-141661 and 333-138984) and Form S-3 (No. 333-194410) of Achillion Pharmaceuticals, Inc. of our report dated February 23, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
February 23, 2017